# Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation

> **NCT06119802** · — · UNKNOWN · sponsor: **Yinglong Hou** · enrollment: 10000 (estimated)

## Conditions studied

- Atrial Fibrillation
- Hyperuricemia

## Interventions

- **DIAGNOSTIC_TEST:** atrial fibrillation

## Key facts

- **NCT ID:** NCT06119802
- **Lead sponsor:** Yinglong Hou
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-04-30
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06119802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06119802, "Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06119802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*